DBD vs BL
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 13, 2026
DBD
60.6
AI Score
VS
DBD Wins
BL
57.2
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | DBD | BL | Winner |
|---|---|---|---|
| Revenue | 891.80M | 183.16M | DBD |
| Net Income | 5.00M | 8.13M | BL |
| Gross Margin | 23.9% | 76.0% | BL |
| Net Margin | 0.6% | 4.4% | BL |
| Operating Income | 32.70M | 6.24M | DBD |
| ROE | 0.5% | 2.7% | BL |
| ROA | 0.1% | 0.6% | BL |
| Total Assets | 3.83B | 1.46B | DBD |
| Cash | 358.60M | 242.04M | DBD |
| Current Ratio | 1.28 | 1.70 | BL |
Frequently Asked Questions
Based on our detailed analysis, DBD is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.